Repurposing psychopharmacology: A two-way street?

Batistela M Vilela-Costa H Frias A , et al. (2021) Enhanced responsiveness to hypoxic panicogenic challenge in female rats in late diestrus is suppressed by short term, low dose fluoxetine: Involvement of the dorsal raphe nucleus and the dorsal periaqueductal gray. Journal of Psychopharmacology 35(12): 1–13.

Berwanger O (2021) Fluvoxamine for outpatients with COVID-19: Where do we stand? Lancet Global Health. Epub ahead of print 27 October. DOI: 10.1016/S2214-109X(21)00501-5.

Da Costa JPOM Bisol LW Souza FGME (2021) Which are the demographic and clinical characteristics of patients who respond to subcutaneous esketamine? Journal of Psychopharmacology. Epub ahead of print 3 August. DOI: 10.1177/02698811211035392.

Dawson GR Post A Smart TS , et al. (2021) Accuracy in recognising happy facial expressions is associated with antidepressant response to a NOP receptor antagonist but not placebo treatment. Journal of Psychopharmacology. Epub ahead of print 5 October. DOI: 10.1177/02698811211044684.

De Giorgi R Martens M Rizzo Pesci N , et al. (2021) The effects of atorvastatin on emotional processing, reward learning, verbal memory, and inflammation in healthy volunteers: An experimental medicine study. Journal of Psychopharmacology 35(12): 1–9.

Faßbender K Bey K Lippold JV , et al. (2021) GABAergic modulation of performance in response inhibition and interference control tasks. Journal of Psychopharmacology. Epub ahead of print 18 July. DOI: 10.1177/02698811211032440.

Faulkner P Paioni SL Kozhuharova P , et al. (2021) Relationship between depression, prefrontal creatine and grey matter volume. Journal of Psychopharmacology. Epub ahead of print 26 October. DOI: 10.1177/02698811211050550.

Frick A Persson J Bodén R (2021) Habitual caffeine consumption moderates the antidepressant effect of dorsomedial intermittent theta burst transcranial magnetic stimulation. Journal of Psychopharmacology 35(12): 1–6.

Garcia P Montastruc JL Rousseau V , et al. (2021) β-adrenoceptor antagonists and nightmares: A pharmacoepidemiological-pharmacodynamic study. Journal of Psychopharmacology. Epub ahead of print 28 July. DOI: 10.1177/02698811211034810.

Lan T Ma YQ Dang YM , et al. (2021) Effects of 31 recombinant CYP2C19 variants on clomipramine metabolism in vitro. Journal of Psychopharmacology. Epub ahead of print 27 October. DOI: 10.1177/02698811211050573.

Milaneschi Y Lamers F Berk M , et al. (2020) Depression heterogeneity and its biological underpinnings: Toward immunometabolic depression. Biological Psychiatry 88(5): 369–380.

Paul P Nadella RK Sen S , et al. (2021) Association study of BDNF Val66Met gene polymorphism with bipolar disorder and lithium treatment response in Indian population. Journal of Psychopharmacology. Epub ahead of print 27 July. DOI: 10.1177/02698811211032609.

Reis G Dos Santos Moreira-Silva EA Silva DCM , et al. (2021) Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: The TOGETHER randomised, platform clinical trial. Lancet Global Health. Epub ahead of print 27 October. DOI: 10.1016/S2214-109X(21)00448-4.

Shiga T Hoshino H Ochiai H , et al. (2021) Effects of benzodiazepine and orexin receptor antagonist on cognitive function revealed by auditory event-related potentials. Journal of Psychopharmacology. Epub ahead of print 30 July. DOI: 10.1177/02698811211035390.

Van Ruitenbeek P Quaedflieg CW Hernaus D , et al. (2021) Dopaminergic and noradrenergic modulation of stress-induced alterations in brain activation associated with goal-directed behaviour. Journal of Psychopharmacology. Epub ahead of print 14 September. DOI: 10.1177/02698811211044679.